Business Context and Reporting Period
Pediatrix Medical Group, Inc. filed its Form 10-Q for the quarterly period ended March 31, 1999. The Company operates as a physician group providing neonatal and perinatal services. As of May 7, 1999, there were 15,502,022 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 1999 | Q1 1998 |
|---|---|---|
| Net Patient Service Revenue | $53,826,000 | $37,808,000 |
| Income from Operations | $12,244,000 | $9,865,000 |
| Net Income | $7,250,000 | $6,119,000 |
| Diluted EPS | $0.45 | $0.39 |
| Operating Cash Flow | $10,507,000 | $6,685,000 |
| Cash and Equivalents (End of Period) | $584,000 | $2,947,000 |
| Total Debt (Line of Credit + Notes) | $11,100,000 | N/A |
| Working Capital | $16,397,000 | N/A |
Debt and Liquidity: The Company maintains a $75 million line of credit with $66.2 million available as of March 31, 1999. Outstanding debt includes $8.8 million on the line of credit and $2.5 million in notes payable. Total assets were $291.0 million.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 42.4% to $53.8 million. Approximately 89.4% of this increase ($14.3 million) was attributable to new units from acquisitions, while same-unit revenue grew 4.9%.
- Expense Increases: Salaries and benefits rose 46.0% to $34.4 million, driven by new physician hires ($7.0 million) and a change in accounting policy to expense acquisition-related costs ($345,000) rather than capitalize them. Supplies and other operating expenses increased 67.9% to $4.5 million.
- Profitability: Net income increased 18.5% to $7.3 million. Operating income grew 24.1% to $12.2 million.
- Cash Flow: Net cash provided by operating activities increased to $10.5 million from $6.7 million. However, investing activities consumed $18.1 million, primarily due to $17.5 million in cash payments for three physician group acquisitions.
Guidance, Outlook, Risks, and Unusual Items
- Acquisitions: The Company acquired three physician groups in Q1 1999 for approximately $17.5 million in cash and 1 million subsidiary shares. Two additional acquisitions totaling $17.9 million were completed subsequent to the period end.
- Legal Proceedings: Seven federal securities class action lawsuits were filed in February 1999 alleging violations regarding accounting practices (capitalization of acquisition payments) and revenue recognition. The Company intends to defend these vigorously. Additionally, state investigators in Arizona, Colorado, and Florida have issued subpoenas regarding billing practices.
- Corporate Actions: On March 31, 1999, the Board adopted a Preferred Share Purchase Rights Plan (poison pill) and amended Bylaws to discourage hostile takeovers.
- Year 2000 Compliance: The Company estimates total costs for Y2K compliance will not exceed $500,000. Testing is expected to be completed by the end of Q3 1999.
- Accounting Change: Effective January 1, 1999, the Company began expensing incremental internal costs related to acquisitions as incurred, rather than capitalizing them.
Investor Verification Checklist
- Verify the status and potential financial impact of the seven federal securities class action lawsuits and state billing investigations.
- Confirm the integration and revenue performance of the three Q1 1999 acquisitions and the two post-period acquisitions.
- Monitor the utilization of the $75 million credit facility given the significant cash outflows for acquisitions.
- Review the Company's response to the change in accounting policy regarding the expensing of acquisition costs.
- Assess the progress of Year 2000 compliance testing and the readiness of third-party payors and vendors.